Navigation Links
Agenda Announced for the BioTechniques 2013 Virtual Symposium on Exploring the Modern Lab
Date:8/30/2013

New York, NY (PRWEB) August 30, 2013

BioTechniques: The International Journal of Life Science Methods announces the Agenda for the BioTechniques 2013 Virtual Symposium on Exploring the Modern Lab. From enhanced PCR protocols to sophisticated imaging techniques enabling nanometer resolution, the sessions, posters and special keynote talks at this year’s event will examine the evolution of key methodologies driving modern research.

Event Date: Wednesday, October 2, 2013
Event Time: 8:30 AM EDT – 6:00 PM EDT

Show Opens
8:30 AM EDT

Session 1: Advancing Molecular Biology
9:00 AM EDT – 10:15 AM EDT
Lecture on cloning / mutagenesis
Lecture on the analysis of gene regulation

The BioTechniques 30th Anniversary Lecture on Gene and Drug Delivery
10:15 AM EDT - 10:45 AM EDT
Lecture on “Novel Drug Delivery Systems: From Controlled Release of Macromolecules to the Current Era of Nanotechnology and Nucleic Acid Delivery”

Session 2: PCR in 2013
11:00 AM EDT – 12:45 AM EDT
Lecture on qPCR
Lecture on multiplex PCR
Lecture on “Digital Genomics and Cancer”

Sponsored Workshop on Plastic Labware Leaching
12:45 PM EDT – 1:45 PM EDT
Title: “Not all Consumables are Created Equal”

Session 3: Understanding Modern Biochemistry
1:45 PM EDT – 3:30 PM EDT
Lecture on “Exploiting Peptide Conformational Changes for Protein Production”
Lecture on “FRET Based Approaches to Protein Structure and Function at the Single Molecule Level”
Lecture on “Molecular Insight Into the Recognition of Membrane Geometry”

Session 4: Modern Cellular Imaging
3:45 PM EDT – 5:30 PM EDT
Lecture on “A Brief History of Time-Lapse Microscopy”
Lecture on “Optimization of Cyan Fluorescent Proteins for FRET”
Lecture on high-content imaging

The 2013 BioTechniques Virtual Symposium is sponsored in part by Chroma, Eppendorf, Essen BioScience, Mirus, Molecular Devices, OriGene, PerkinElmer, QMI, Quanta Biosciences, Roche, and Shimadzu.

To register for the 2013 BioTechniques Virtual Symposium and help BioTechniques celebrate the scientists and methods developers who continue to change the way researchers work in the lab, please visit: http://bit.ly/17e7DmZ.

About BioTechniques

BioTechniques, the international journal of life science methods, provides open access to first-quality, peer-reviewed papers on laboratory techniques and protocols. Now in its 56th volume, BioTechniques has over 80,000 print subscribers worldwide. The journal augments its peer-reviewed content with feature articles and topic-specific supplements. Visit http://www.biotechniques.com for more details or to subscribe.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11079985.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Agenda set for upcoming CRF-sponsored conference on stem cell therapy for heart disease
2. Final agenda available for CRF sponsored conference on stem cell therapy for heart disease
3. Final agenda available for CTO and Left Main Summit to be held Feb. 21-23, 2013 in NYC
4. 21st Annual Primary Care Live CME Conference Agenda for July 2013 released by Continuing Education Company
5. Florida Lawmakers Agenda Against the Future of Medical and Recreational Marijuana in Florida May Have Severe Repercussions, as Reported by PotStores.com
6. First Cousins Edutainment Introduces the (1st cousins edt) Central Mobile App; Available at No Cost; Major Upgrade Can be Obtained; #1 Entertainment, Agenda & Planning.
7. Global Spa & Wellness Summit Unveils 2013 Conference Agenda
8. Lucian Leape Institute at the National Patient Safety Foundation Announces Agenda for 6th Annual Forum & Gala
9. First recipients of AcademyHealths Presidential Scholarship announced
10. Patient Experience Regional Roundtables Announced by The Beryl Institute
11. SupplementsToWeightLoss LLC (DBA: PharmaCo Labs) and also Classe Wines LLC announced that they have signed a 5 years lease on a warehouse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
(Date:6/24/2016)... ... 2016 , ... Finally, a bruise cream that really works. Originally designed ... into the post-surgical treatment plans of a variety of other procedures including, but not ... effective for bruising and causes a rapid resolution of bruising and inflammatory changes compared ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, InhaleLabs.com (Inhale) offilially launched its site, ... matching users with high quality water pipes within an ideal price range. The site ... was founded by two brothers, Nick and Mike Hunter, who use medical cannabis to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
(Date:6/23/2016)... ... June 23, 2016 , ... The Mechille Wilson Agency, ... throughout Jasper County and the surrounding region, is initiating a charity drive to assist ... raise funds earmarked for a scholarship fund that will be presented to the chosen ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: